Vincent O'Neill

Chief Medical Officer, SYNLOGIC, INC.

Companies

BioXcel Therapeutics, Inc.Chief Medical Officer Mar 7, 2018 to Dec 17, 2024¹
SYNLOGIC, INC.Chief Medical Officer Apr 26, 2016 to Apr 26, 2016²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 16, 2024Sold 165 shares at $0.35 of BioXcel Therapeutics, Inc.³
Dec 14, 2024Exercised options 521 shares of BioXcel Therapeutics, Inc.³
Oct 3, 2024Sold 5,556 shares at $0.55 of BioXcel Therapeutics, Inc.⁴
Sep 17, 2024Granted 21,250 shares of BioXcel Therapeutics, Inc.⁴
Sep 16, 2024Sold 138 shares at $0.69 of BioXcel Therapeutics, Inc.⁵
Sep 14, 2024Exercised options 521 shares of BioXcel Therapeutics, Inc.⁵
Jun 17, 2024Sold 155 shares at $1.29 of BioXcel Therapeutics, Inc.⁶
Jun 14, 2024Exercised options 521 shares of BioXcel Therapeutics, Inc.⁶
Apr 4, 2024Sold 165 shares at $2.62 of BioXcel Therapeutics, Inc.⁷
Mar 15, 2024Exercised options 2,250 shares of BioXcel Therapeutics, Inc.⁷
Mar 14, 2024Exercised options 521 shares of BioXcel Therapeutics, Inc.⁷
Dec 14, 2023Exercised options 521 shares of BioXcel Therapeutics, Inc.⁸
Sep 14, 2023Exercised options 521 shares of BioXcel Therapeutics, Inc.⁹
Jun 14, 2023Exercised options 521 shares of BioXcel Therapeutics, Inc.¹⁰
Mar 15, 2023Sold 845 shares at $19.70 of BioXcel Therapeutics, Inc.¹¹
Mar 14, 2023Exercised options 2,084 shares of BioXcel Therapeutics, Inc.¹¹
Jan 20, 2023Sold 29,713 shares at $30.00 of BioXcel Therapeutics, Inc.¹²
Jan 20, 2023Exercised options 29,713 shares at $0.41 of BioXcel Therapeutics, Inc.¹²

The numbers on this page point here. Each one links to the record it came from.